Financials data is unavailable for this security.
View more
Year on year Medirom Healthcare Technologies Inc 's net income fell -22.53% from 148.97m to 115.40m despite relatively flat revenues. A contributing factor has been an increase in the percentage of sales devoted to the cost of goods sold from 72.64% to 77.02%.
| Gross margin | 22.98% |
|---|---|
| Net profit margin | 1.68% |
| Operating margin | -5.73% |
| Return on assets | 1.69% |
|---|---|
| Return on equity | 152.35% |
| Return on investment | 3.60% |
More ▼
Cash flow in JPYView more
In 2023, cash reserves at Medirom Healthcare Technologies Inc fell by 499.11m. Cash Flow from Financing totalled 461.21m or 6.75% of revenues. In addition the company used 631.74m for operations while cash used for investing totalled 328.58m.
| Cash flow per share | 0.4989 |
|---|---|
| Price/Cash flow per share | 7.54 |
| Book value per share | 0.3028 |
|---|---|
| Tangible book value per share | -1.72 |
More ▼
Balance sheet in JPYView more
| Current ratio | 0.4939 |
|---|---|
| Quick ratio | 0.4546 |
| Total debt/total equity | 7.36 |
|---|---|
| Total debt/total capital | 0.8778 |
More ▼
Growth rates in JPY
Year on year, growth in earnings per share excluding extraordinary items dropped -17.97%. Additionally, five year annualized earnings per share growth is in-line with the industry average relative to its peers.
| EPS growth(5 years) | 10.19 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -21.75 |
